Genprex公司已正式签署一项资助研究协议,旨在系统研究可能预测患者对Reqorsa®基因疗法治疗反应的生物标志物。该研究将深入分析特定分子指标,以期建立更精准的患者响应预测模型,为个性化治疗方案提供科学依据。
Genprex公司已正式签署一项资助研究协议,旨在系统研究可能预测患者对Reqorsa®基因疗法治疗反应的生物标志物。该研究将深入分析特定分子指标,以期建立更精准的患者响应预测模型,为个性化治疗方案提供科学依据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.